Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 111 days ( -2.08 % )
Last Price $14.74 0 %
High/ Low $14.74 - $14.74 0%
Chg 7 Days N/A $14.74 $14.74
Chg 30 Days N/A $14.74 $14.74
Chg 12 mos 40.51 % $10.49 $14.74
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 83.43 % Width: 74.56 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $19.10 - $33.33 29.55 % - 126.14 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Jun 12, 2023 - 74 days
Long MA avg 12 mos Buy Apr 17, 2023 - 113 days
Short/Long MA avg 12 mos Buy Apr 20, 2023 - 110 days
Pivot Short Sell Sep 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Bellus Health Inc.

Bellus Health. BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.... BLU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT